Cerebral microbleeds (CMBs) are defined as hypointense foci visible on T2*-weighted and
susceptible-weighted MRI sequences. CMBs are increasingly recognised with the …

Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …

Intracranial hemorrhage is one of the most feared complications following brain infarct.
Ischemic tissues have a natural tendency to bleed. Moreover, the first recanalization trials …

Background and Objectives Cerebral microbleeds (CMBs) are common in patients with
acute ischemic stroke and are associated with increased risk of intracerebral hemorrhage …

Background: Symptomatic intracerebral hemorrhage (sICH) and major bleeding can be fatal
complications of intravenous thrombolysis (IVT) for acute ischemic stroke. We investigated …

Intravenous thrombolysis (IVT) represents the only systemic reperfusion therapy able to
reverse neurological deficit in patients with acute ischemic stroke (AIS). Despite its …

Balancing the risks of recurrent ischemia and antithrombotic-associated bleeding,
particularly intracranial hemorrhage (ICH), is a key challenge in the secondary prevention of …

Objective To determine whether pretreatment cerebral microbleeds (CMBs) presence and
burden are correlated with an increased risk of intracranial hemorrhage (ICH) or poor …

Abstract Background and Purpose The association between the cerebral microbleed (CMB)
count and outcomes in ischemic stroke has not been fully clarified. The aim of this study was …

Background: Cerebral microbleeds (CMBs), a notable neuroimaging finding often
associated with cerebral microangiopathy, demonstrate a heightened prevalence in patients …